Related Experiment Video

Updated: Apr 14, 2026

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

18.3K

Comparative Effectiveness of Rituximab in Treatment-Naïve vs. Switch Patients with Multiple Sclerosis: A Real-World

Hosna Elshony1,2, Rakan Almuhanna3, Abdulaziz Al-Ghamdi3

  • 1Department of Internal Medicine, Neurology Unit, Security Forces Hospital, Makkah, Saudi Arabia. hosna.saad28@gmail.com.

Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|April 13, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Annualized Relapse RateMultiple SclerosisNEDAReal-World EvidenceRituximabSwitch TherapyTreatment-Naïve

More Related Videos

Induction and Assessment of Class Switch Recombination in Purified Murine B Cells09:49

Induction and Assessment of Class Switch Recombination in Purified Murine B Cells

Published on: August 13, 2010

19.6K
Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies09:54

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on: May 22, 2020

4.0K

Related Concept Videos